Results 81 to 90 of about 32,524 (285)

Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals. [PDF]

PLoS ONE, 2015
The validity of continuous glucose monitoring (CGM) is well established in diabetic patients. CGM is also increasingly used for research purposes in normo-glycemic individuals, but the CGM validity in such individuals is unknown.
Abimbola A Akintola, Raymond Noordam, Steffy W Jansen, Anton J de Craen, Bart E Ballieux, Christa M Cobbaert, Simon P Mooijaart, Hanno Pijl, Rudi G Westendorp, Diana van Heemst   +9 more
doaj   +1 more source

Glycemic Variability: Risk Factors, Assessment, and Control [PDF]

Journal of Diabetes Science and Technology, 2019
Glycemic variability (GV) a well-established risk factor for hypoglycemia and a suspected risk factor for diabetes complications. GV is also a marker of the instability of a person’s metabolic system, expressed as frequent high and low glucose excursions and overall volatile glycemic control.
openaire   +3 more sources

Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination? [PDF]

Frontiers in Microbiology, 2017
Following the 2009 H1N1 influenza virus pandemic, numerous studies identified the striking link between diabetes mellitus and influenza disease severity. Typically, influenza virus is a self-limiting infection but in individuals who have a pre-existing chronic illness, such as diabetes mellitus, severe influenza can develop. Here, we discuss the latest
Katina D. Hulme, Linda A. Gallo, Linda A. Gallo, Kirsty R. Short, Kirsty R. Short   +4 more
openaire   +5 more sources

Phenolic Compounds From Myrcia tijucensis: Insights Into Antioxidant and Antidiabetic Activities

Chemistry &Biodiversity, EarlyView.
ABSTRACT The genus Myrcia from the Myrtaceae family contains species with therapeutic properties, such as reducing glycemia and oxidative stress. This study investigated the effects of the hydroalcoholic extract of Myrcia tijucensis in an animal model of Type 1 diabetes induced by alloxan.
Nathielli Nayara Pauleti, Brenda Wiggers, Ana Luiza de Moraes G. Boaventura, Ana Carolina Dutra, Luiz Guilherme de Alcantara Grilo, Jan Pereira Wotmeyer, Camila Jeriane Paganelli, Camila Panini, Rafaela Beatriz Cunha, Michele Debiasi Alberton, Luciano Vitali, Gustavo Amadeu Micke, Daniela Delwing‐de Lima, Débora Delwing‐Dal Magro   +13 more
wiley   +1 more source

The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review

Diabetes, Metabolic Syndrome and Obesity, 2021
Keyu Guo,* Qi Tian,* Lin Yang, Zhiguang Zhou National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of ...
Guo K, Tian Q, Yang L, Zhou Z
doaj  

Managing Diabetes One Step at a Time in Low‐ and Middle‐Income Countries: The Promise of Wearable Devices

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT The global burden of diabetes mellitus disproportionately affects low‐ and middle‐income countries (LMICs), where limited healthcare infrastructure hampers timely and effective disease management. Wearable technologies, such as continuous glucose monitors (CGMs), insulin pumps, and fitness trackers, offer a transformative opportunity to bridge
Safayet Jamil, Masoud Mohammadnezhad, Abdulrakib Abdulrahim, Faisal Muhammad, Hafiz T. A. Khan   +4 more
wiley   +1 more source

Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data

Clinical Pharmacology &Therapeutics, EarlyView.
This study compared the number and cumulative dose of antibiotic dispensings among new users of sodium–glucose cotransporter‐2 (SGLT2) inhibitors and dipeptidyl peptidase‐4 (DPP4) inhibitors following hospital discharge in individuals with type 2 diabetes.
Maria J. Alfonso Arvez, George S. Q. Tan, Sam Wade, Zanfina Ademi, Jenni Ilomäki, J. Simon Bell   +5 more
wiley   +1 more source

Effects of Sensor-Augmented Pump Therapy on Glycemic Variability in Well-Controlled Type 1 Diabetes in the STAR 3 Study [PDF]

, 2012
John B. Buse, Yogish C. Kudva, Tadej Battelino, Stephen N. Davis, John Shin, John Welsh   +5 more
openalex   +3 more sources

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals

Clinical Pharmacology &Therapeutics, EarlyView.
Data science approaches have been increasingly implemented in healthcare big data to evaluate the safety and effectiveness of drugs. Association discovery is a data mining approach that finds potentially associated elements in high‐dimensional data. We present a novel implementation of the association discovery approach in longitudinal healthcare data ...
George S. Q. Tan, Lynn Miller, Sam Wade, Jenni Ilomäki, Dickson Lukose, Jia Rong, Geoffrey I. Webb   +6 more
wiley   +1 more source

Streptozotocin induced hyperglycemia in the axolotl

Developmental Dynamics, EarlyView.
Abstract Background Diabetes is a group of diseases characterized by loss of β cell mass and/or function, resulting in hyperglycemia. With no established curative treatment, this has initiated research in β cell regeneration. Current animal models have either limited regenerative capacity (mice) or small size and evolutionary distance from humans ...
Pernille Lajer Sørensen, Anita Dittrich, Henrik Lauridsen   +2 more
wiley   +1 more source